Literature DB >> 9609804

Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro.

A C Villablanca1.   

Abstract

Nicotine is a major component of cigarette smoke and has been postulated to play an important role in atherogenesis and malignancy. Endothelial cell growth may be regulated by nicotine, yet operative mechanisms at the endothelial level are poorly understood. We studied the effects of nicotine (10(-14)-10(-4) M) on endothelial DNA synthesis, DNA repair, proliferation, and cytotoxicity by using cultures of bovine pulmonary artery endothelial cells. Assays were performed on cells incubated with nicotine in the presence and absence of hydroxyurea (an inhibitor of scheduled DNA synthesis), serum, human platelet-poor plasma, and platelet-derived growth factor and endothelial cell growth factor (PDGF and PDECGF, respectively). Nicotine significantly stimulated endothelial cell DNA synthesis and proliferation at concentrations lower than those obtained in blood after smoking (<10(-8) M). The stimulatory effects of nicotine were enhanced by serum (0.5%) and PDECGF and were blocked by the nicotinic-receptor antagonist hexamethonium. The response to nicotine was bimodal because cytotoxicity was observed at higher concentrations (>10(-6) M). This study has implications for understanding cellular mechanisms of nicotine action. The results may be important in tumor angiogenesis, atherogenesis, and vascular dysfunction in smokers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609804     DOI: 10.1152/jappl.1998.84.6.2089

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  52 in total

1.  Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?

Authors:  Edwin Chang; E Camilla Forsberg; Jenny Wu; Susan S Prohaska; Rich Allsopp; Irving L Weissman; John P Cooke
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

2.  A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.

Authors:  Christopher Heeschen; Michael Weis; Alexandra Aicher; Stefanie Dimmeler; John P Cooke
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 3.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts.

Authors:  Gouri Shanker; Jimmy L Kontos; Delrae M Eckman; Deborah Wesley-Farrington; David C Sane
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

5.  Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis.

Authors:  Michael J Jarzynka; Ping Guo; Ifat Bar-Joseph; Bo Hu; Shi-Yuan Cheng
Journal:  Int J Oncol       Date:  2006-02       Impact factor: 5.650

Review 6.  Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.

Authors:  John P Cooke
Journal:  Life Sci       Date:  2007-02-17       Impact factor: 5.037

Review 7.  Effects of tobacco smoking and nicotine on cancer treatment.

Authors:  William P Petros; Islam R Younis; James N Ford; Scott A Weed
Journal:  Pharmacotherapy       Date:  2012-10       Impact factor: 4.705

Review 8.  Endothelial nicotinic acetylcholine receptors and angiogenesis.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

9.  Chronic exposure to nicotine impairs cholinergic angiogenesis.

Authors:  Hakuoh Konishi; Jenny Wu; John P Cooke
Journal:  Vasc Med       Date:  2009-09-24       Impact factor: 3.239

10.  Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.

Authors:  Katsuji Kiuchi; Masato Matsuoka; Jenny C Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; John P Cooke; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.